Biotheranostics presents new studies of the Breast Cancer Index(R) at the 2020 ASCO conference, expanding its clinical utility as a predictive tool for hormone receptor positive, early-stage breast cancer

Source :: GlobeNewswire. May 29, 2020
Publication Year :: 2020
Abstract: San Diego, CA, May 29, 2020 (GLOBE NEWSWIRE via COMTEX) -- Biotheranostics announces several new studies demonstrating comprehensive validation and clinical utility of its Breast Cancer Index genomic assay for [...]

Subjects :: Hormones -- Conferences, meetings and seminars
Cancer genetics -- Conferences, meetings and seminars
Cancer research -- Conferences, meetings and seminars
Patient compliance -- Conferences, meetings and seminars
Breast cancer -- Conferences, meetings and seminars
Genetic research
Letrozole
Clinical trials
Aromatase inhibitors
Professional associations
Cancer patients
Banking, finance and accounting industries
Business

Tools